Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
LMAO xD
I couldn’t find the word Brilacidin anywhere. Maybe need to use the “find” tool.
This means to me:
No Grants. No Preprints.
Ol’ Leo’s Sleazy ways.
Overpromise and UNDERDELIVER!!
September to FORGET.
Nothing is happening and that’s why this article from the New Yorker late on a Monday.
Remember when leo used to post IPIX blogs related to Prurisol about possible revenue all these to pretend everything was going great?
Zero Execution Snail Speed Leo.
Sava flying high on minor improvements on biomarkers and insiders loading up.
Are we late to the sigma-1 race?
By February 2021 we will have missed our chance. We are super late as it is.
All talk, No execution.
Another embarrassment in Leo’s management skills.
We say that every Monday while Leo is on vacations right now XD LOL
No sense of urgency with Leo’s Snail Speed. He has to milk this Pandemic until the end cha-ching for him every Friday!!!
“If it Sounds Too Good to Be True, it Probably Is”
This quote is essential when investing in OTC Lalaland. Who would’ve thought that CV PRs started back in February and still we haven’t started any trials. People here were pumping about an avalanche of Positive PRs that will propel IPIX into dollar range. Well, it’s Leo’s holidays so forget about that...
Yeah. ZERO Urgency to get the CV Killer on Human Trials!!!
“Hell, Signing up Aspire was the obvious clue that Leo’s on his on...”
Sleazy Leo that’s why he didn’t do a PR.
He knows we ain’t getting $#it. He’s not trustworthy not even to Tax Payers money.
That’s a good size commitment.
I like that.
And with Holidays already started people will start excusing Leo saying, “well he stole B for $5M so he deserves some time off” hope this year he skips holidays and gets his ass to work. Tired of paying his undeserved salary. C’mon leo, being some value to the table now.
Leo’s Snail Speed trying to milk this pandemic with pumping PR’s and no
Execution will get us thru this year and then back to pennies when competitors beat us. Going as slow as Kevetrin back in 2012 trying to find MTD.
If the “Gold Standard 97.5% CV Killer...”
Why no preprints?
Why no Grants?
Why no Partnerships?
Why no Buyouts?
Just like always no trust, no leadership, no money, no execution just fantasy and hoping for next Monday to turn the page for the last 5 years.
Agree with you. This double blind should start a Snowball effect IF positive Topline data.
World Alzheimer’s Day is Monday September 21st.
Could be a Great day to release some Parkinson DEMENTIA Disease Topline data.
JK, probably they will release on the 28th.
Pre-Print Monday?
Leo needs to start swinging Hard.
From Who?
$5-8B buyout sounds appetizing...
Leo doesn’t have the knowledge, credibility, team or infrastructure to push B into the Market. Best case scenario will be to sell everything including the parrot and dog.
I wish I could sell everything for $1.67 right now.
What a waste of 8 years.
Don’t trust Leo, but to red to sell right now.
Can you provide a link where it proves Brilacidin is being considered by Gilead?
If so, we would be trading in the dollar range by now.
Can you provide a link or proof of your statement?
Don’t think so.
They don’t even know we exist.
Boom!! Right in the Kisser CyberB!!!
@InnovationPharma5 is tweeting and adding Gilead to their post. Whoever owns that account is trying to get their attention.
Everything sounds amazing on paper, but we need to go to Human Trials ASAP.
Humans trials may start until November and by then we would have miss the boat.
If RBLs are seeing wonders and huge potential at fighting CV19 with Brilacidin, why aren’t they expediting the process?
Why no WARP Speed for IPIX?
Leo’s dubious character and terrible performance also doesn’t help at all...
Posts like this encourage greed and goal is to get more people trapped on this.
I’ve seen it across multiple OTCs boards.
Aspire and Leo make money every week regardless. It’s us who pay the price and yes hype is dying with Elections coming up and hundreds of other contenders WAY ahead of us in the CV cure race.
Yesterday’s pump of GILD’s buyout was fun though.
Dude, for real...
Leo’s Snail Speed will kill Briladicin and IPIX.
“Further, anyone who is “paying attention” should know that a mouse model is a very poor model for humans and some studies suggest murine models have a 49% chance of yielding discordant results to humans.”
100% agree. Remember how leo showed those mice that were Psoriasis free with Prurisol? Yeah that was a waste of time and money
“Maybe there is a GILD/IPIX joint clinical trial in the planning phase”
Leo is a Jumpy CEO and he would’ve PR that First thing in the morning. Right now he doesn’t have any partnership or grants since he keeps adding the next at end of PR’s:
“For researchers and institutions interested in collaborating on Brilacidin for COVID-19, please send inquiries to: covid19@ipharminc.com”
So Leo got himself a loan to pay his salary and we’ll pay 1% interest in the next 2 years?
Like always Leo only taking care of the only thing that matters to him, his salary.
Back to .22 and might go lower.
The Dilution machine is ON until next PR.
Leo is using Remdesivir to extend his salary pass June 2021.
Pump is dying. Retracing back to .22
The .65 pump was for the MFO to unload and make millions
Where’s WARP speed when needed?!
Get that B+R Combo tested ASAP!!!
Leo and the Dilution Machine is ON.
We’ll close at $.25 and then trace back to $.22
https://www.foxnews.com/health/university-pittsburgh-antibody-neutralizes-coronavirus
We are late to the CV Treatment too.
That paragraph doesn’t mean anything. Leo is a Liar. This is from Holidays 2016.
“Looking ahead to 2017, we intend to remain laser focused on advancing our clinical pipeline with concurrent nurturing of relationships that can potentially lead to partnerships. Productive initial dialogue with major pharmaceutical companies in 2016 has already provided clear directions”
Gold Standard is Dead too.
If it sounds too good to be true.... you know the rest.
Definitely.
No reason to stay above .20 cents with no clinical trials, partnerships or grants on sight this year.
Sometime I just wish Leo wouldn’t PR stuff until they are reality.
Looks like another awkward Thanksgiving.
My wife and I discussed back in July that start of clinical trials in September for CV was late, but better late than never...Now it looks like we’ll miss this year and B will miss the hype.
Another awkward Thanksgiving with no clinical trials. Glad Leo is still making money. WHAT AN SOB!!!
Silence Is deadly under Leo.
No wonder no PRs.
He was about to pull the rug from our feet one more time, bad news buried on the 10-K